Novartis Pharmaceuticals Corporation Drug Works For Parkinson's Says FDA Staffer

An Alzheimer's drug made by Novartis Pharmaceuticals effectively treats dementia in patients with Parkinson's disease, but it is unclear if such mental impairments are two distinct conditions, U.S. Food and Drug Administration staff said on Tuesday.

Back to news